As a result of prolonged use and overuse of nasal decongestants, the Belgian Health Authorities have decided to switch intranasal corticosteroids to OTC-status. OTC-use is recommended especially for intranasal corticosteroids with low systemic absorption e.g. mometasone and fluticasone. These days, a good opportunity for the public pharmacists to stress their advising role and point out to patients that, unlike the nasal vasoconstrictors, there will be no immediate relieve when using intranasal corticosteroids.

Share This